Meyka Pro banner
Alpha Teknova, Inc.

Alpha Teknova, Inc. (TKNO) Stock Overview

Explore Alpha Teknova, Inc.’s financial performance, market position, analyst ratings, and future outlook.

TKNONASDAQ
HealthcareDrug Manufacturers - Specialty & Generic
$7.54
$0.50(7.10%)
U.S. Market is Open · 13:57

Alpha Teknova, Inc. (TKNO)

Meyka AI Score

Z

Key Financials

Market Cap396.2M
P/E Ratio-23.26
EPS (TTM)$-0.31
ROE-0.25%
Fundamental Analysis

AI Price Forecasts

1 Month$4.45
3 Months$8.51
1 Year Target$4.42

TKNO Stock Analysis & Investment Overview (NASDAQ)

Our AI-powered analysis of Alpha Teknova, Inc. (NASDAQ: TKNO) gives investors deep insight into how the stock performs on the NASDAQ exchange, its growth potential, and its market positioning. With a Meyka AI Score of B, Alpha Teknova, Inc.'s NASDAQ-listed shares demonstrate moderate investment characteristics based on our machine learning models.

The current technical analysis of TKNO on the NASDAQ shows an RSI of 79.89, suggesting the stock is in a an overbought condition. Our forecasting models predict a 12-month price target of $4.42 for the NASDAQ listing.

Key metrics behind Alpha Teknova, Inc.'s NASDAQ-traded stock include a P/E ratio of -23.26 and a market capitalization of 396.2M. Combined with our AI analysis, these give both institutional and retail investors a clear view of TKNO on the NASDAQ.

Price Performance (NASDAQ: TKNO)

1-Day Change
4.97%
5-Day Change
13.17%
1-Month Change
37.87%
3-Month Change
85.21%
6-Month Change
246.95%
Year-to-Date (YTD) Change
94.47%
1-Year Change
54.60%
3-Year Change
177.82%
5-Year Change
-62.30%
All-Time (Max) Change
-70.44%

Contact Information

831 637 1100
2290 Bert Drive, Hollister, CA, 95023

Company Facts

1,580 Employees
IPO DateJun 25, 2021
CountryUS
Actively Trading

Frequently Asked Questions